1. YAP/TAZ Signaling and Resistance to Cancer Therapy
    Chan D.K. Nguyen et al, 2019, Trends in Cancer CrossRef
  2. Immunohistochemical Localization of YAP and TAZ in Mouse Incisor Tooth Germ
    Tetsuya Sugizaki et al, 2024, International Journal of Oral-Medical Sciences CrossRef
  3. Control of stem cell renewal and fate by YAP and TAZ
    Jordan H. Driskill et al, 2023, Nature Reviews Molecular Cell Biology CrossRef
  4. Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapy
    Francesca Reggiani et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  5. Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells
    Wei Zhou et al, 2024, Free Radical Biology and Medicine CrossRef
  6. Identification of a Gene Signature That Predicts Dependence upon YAP/TAZ-TEAD
    Ryan Kanai et al, 2024, Cancers CrossRef
  7. FOXC2 positively regulates YAP signaling and promotes the glycolysis of nasopharyngeal carcinoma
    Lijuan Song et al, 2017, Experimental Cell Research CrossRef
  8. Functions of Yes-association protein (YAP) in cancer progression and anticancer therapy resistance
    Yu Zhang et al, 2022, Brain Science Advances CrossRef
  9. Active nanomaterials containing YAPTAZ reshape tumor immune microenvironment and enhance sensitivity of triple-negative breast cancer to immunotherapy
    Xiaohui Liu et al, 2022, Materials Express CrossRef
  10. METTL3 stabilization by PIN1 promotes breast tumorigenesis via enhanced m6A-dependent translation
    Poshan Yugal Bhattarai et al, 2023, Oncogene CrossRef
  11. YAP/TAZ-mediated resistance to EGFR inhibitors
    Hirohito Yamaguchi et al, 2023, Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC CrossRef
  12. Downregulation of RASSF6 promotes breast cancer growth and chemoresistance through regulation of Hippo signaling
    Zheng He et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  13. The Role of the Hippo Pathway in Breast Cancer Carcinogenesis, Prognosis, and Treatment: A Systematic Review
    Anastasios Kyriazoglou et al, 2021, Breast Care CrossRef
  14. Lactate is a potential promoter of tamoxifen resistance in MCF7 cells
    Valentina Rossi et al, 2022, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
  15. TAZ overexpression is associated with epithelial-mesenchymal transition in cisplatin-resistant gastric cancer cells
    Liang Ge et al, 2017, International Journal of Oncology CrossRef
  16. Immunohistochemical Localization of YAP and TAZ in Mouse Molar Tooth Germ
    Yuichiro Okada et al, 2023, International Journal of Oral-Medical Sciences CrossRef
  17. YAP and TAZ: Monocorial and bicorial transcriptional co-activators in human cancers
    Federica Lo Sardo et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  18. YAP/TAZ Activation as a Target for Treating Metastatic Cancer
    Janine Warren et al, 2018, Cancers CrossRef
  19. Analysis of chromatin accessibility uncovers TEAD1 as a regulator of migration in human glioblastoma
    Jessica Tome-Garcia et al, 2018, Nature Communications CrossRef
  20. Extracts of Perilla frutescens var. Acuta (Odash.) Kudo Leaves Have Antitumor Effects on Breast Cancer Cells by Suppressing YAP Activity
    Cho-Long Kim et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  21. Immunohistochemical Localization of YAP and TAZ in Tongue Wound Healing
    Noda Hajime et al, 2019, International Journal of Oral-Medical Sciences CrossRef
  22. Rottlerin inhibits cell growth, induces apoptosis and cell cycle arrest, and inhibits cell invasion in human hepatocellular carcinoma
    Jichan Shi et al, 2017, Molecular Medicine Reports CrossRef
  23. PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein
    Amir Kedan et al, 2018, Cell Death & Disease CrossRef